Corticosteroid-insensitive asthma: Molecular mechanisms

Journal of Endocrinology

Volumn 178, Issue 3, 2003, Pages 347-355

  Adcock, Ian M ^b   Lane, S J ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANNEXIN; ANTIINFLAMMATORY AGENT; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLARA CELL PROTEIN; CORTICOSTEROID; CYTOKINE; DEXAMETHASONE; GLUCOCORTICOID; I KAPPA B ALPHA; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NITRIC OXIDE; PREDNISOLONE; PROTEIN KINASE; RU 24858; RU 40066; SCAVENGER RECEPTOR; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SELECTIVE GLUCOCORTICOID RECEPTOR AGONIST; STEROID; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; ASTHMA; CHRONIC INFLAMMATION; CLINICAL FEATURE; CORTICOSTEROID INDUCED OSTEOPOROSIS; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG ABSORPTION; DRUG MEGADOSE; DRUG POTENCY; DRUG RESPONSE; DRUG SAFETY; ENTERITIS; GLAUCOMA; GROWTH RETARDATION; HEALTH CARE COST; HUMAN; INFLAMMATORY DISEASE; METABOLIC DISORDER; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; WOUND HEALING IMPAIRMENT;

ADULT; ANTI-INFLAMMATORY AGENTS; ASTHMA; CHILD; DRUG RESISTANCE, MULTIPLE; GENE EXPRESSION; HUMANS; INTERLEUKINS; MAP KINASE SIGNALING SYSTEM; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, GLUCOCORTICOID; TRANSCRIPTION FACTOR AP-1; TREATMENT FAILURE;

EID: 0141507943     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1780347     Document Type: Article

References (51)

1. Adcock IM & Caramori G 2001 Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunology and Cell Biology 79 376-384.
2. Adcock IM, Lane SJ, Brown CR, Lee TH & Barnes PJ 1995a Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma. Journal of Experimental Medicine 182 1951-1958.
3. Adcock IM, Lane SJ, Brown CR, Peters MJ, Lee TH & Barnes PJ 1995b Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma. Journal of Immunology 154 3500-3505.
4. Baldwin AS Jr 2001 Series introduction: the transcription factor NF-kappaB and human disease. Journal of Clinical Investigation 107 3-6.
5. Barnes PJ 1995 Inhaled glucocorticoids for asthma. New England Journal of Medicine 332 868-875.
6. Barnes PJ & Karin M 1997 Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. New England Journal of Medicine 336 1066-1071.
7. Barnes PJ, Greening AP & Crompton GK 1995 Glucocorticoid resistance in asthma. American Journal of Respiratory and Critical Care Medicine 152 S125-S140.
8. Belvisi MG, Wicks SL, Battram CH, Bottoms SE, Redford JE, Woodman P, Brown TJ, Webber SE & Foster ML 2001 Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity. Journal of Immunology 166 1975-1982.
9. Caelles C, Gonzalez-Sancho JM & Munoz A 1997 Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Genes and Development 11 3351-3364.
10. Chang L & Karin M 2001 Mammalian MAP kinase signalling cascades. Nature 410 37-40.
11. Corrigan CJ, Brown PH, Barnes NC, Szefler SJ, Tsai JJ, Frew AJ & Kay AB 1991 Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. American Reviews in Respiratory Disease 144 1016-1025.
12. Demoly P, Basset SN, Chanez P, Campbell AM, Gauthier RC, Godard P, Michel FB & Bousquet J 1992 c-fos proto-oncogene expression in bronchial biopsies of asthmatics. American Journal of Respiratory and Cell Molecular Biology 7 128-133.
13. Dong Y, Poellinger L, Gustafsson JA & Okret S 1988 Regulation of glucocorticoid receptor expression: evidence for transcriptional and posttranslational mechanisms. Molecular Endocrinology 2 1256-1264.
14. Gagliardo R, Chanez P, Vignola AM, Bousquet J, Vachier I, Godard P, Bonsignore G, Demoly P & Mathieu M 2000 Glucocorticoid receptor alpha and beta in glucocorticoid dependent asthma. American Journal of Respiratory and Critical Care Medicine 162 7-13.
15. Galigniana MD, Piwien-Pilipuk G & Assreuy J 1999 Inhibition of glucocorticoid receptor binding by nitric oxide. Molecular Pharmacology 55 317-323.
16. Ghosh S & Karin M 2002 Missing pieces in the NF-kappaB puzzle. Cell 109 (Suppl) S81-S96.
17. De Groot RP, van Dijk TB, Caldenhoven E, Coffer PJ, Raaijmakers JA, Lammers JW & Koenderman L 1997 Activation of 12-O-tetradecanoylphorbol-13-acetate response element-and dyad symmetry element-dependent transcription by interleukin-5 is mediated by Jun N-terminal kinase/stress-activated protein kinase kinases. Journal of Biological Chemistry 272 2319-2325.
18. Hart LA, Krishnan VL, Adcock IM, Barnes PJ & Chung KF 1998 Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. American Journal of Respiratory and Critical Care Medicine 158 1585-1592.
19. Hearing SD, Norman M, Probert CS, Haslam N & Dayan CM 1999 Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes. Gut 45 382-388.
20. Hirasawa N, Sato Y, Fujita Y, Mue S & Ohuchi K 1998 Inhibition by dexamethasone of antigen-induced c-Jun N-terminal kinase activation in rat basophilic leukemia cells. Journal of Immunology 161 4939-4943.
21. Irusen E, Matthews JG, Takahashi A, Barnes PJ, Chung KF & Adcock IM 2002 p38 mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. Journal of Allergy and Clinical Immunology 109 649-657.
22. Ito K, Barnes PJ & Adcock IM 2000 Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1 beta- induced histone H4 acetylation on lysines 8 and 12. Molecular Cell Biology 20 6891-6903.
23. Kam JC, Szefler SJ, Surs W, Sher ER & Leung DY 1993 Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. Journal of Immunology 151 3460-3466.
24. Karin M 1998 New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable? Cell 93 487-490.
25. Kassel O, Sancono A, Kratzschmar J, Kreft B, Stassen M & Cato AC 2001 Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO Journal 20 7108-7116.
26. Lamberts SW, Huizenga AT, de LP, de JF & Koper JW 1996 Clinical aspects of glucocorticoid sensitivity. Steroids 61 157-160.
27. Lane SJ & Lee TH 1991 Glucocorticoid receptor characteristics in monocytes of patients with corticosteroid-resistant bronchial asthma. American Review of Respiratory Disease 143 1020-1024.
28. Lane SJ & Lee TH 1996 Corticosteroid resistance in other disease states and tissues. American Journal of Respiratory and Critical Care Medicine 154 S62-S65.
29. Lane SJ, Arm JP, Staynov DZ & Lee TH 1994 Chemical mutational analysis of the human glucocorticoid receptor cDNA in glucocorticoid-resistant bronchial asthma. American Journal of Respiratory Cell and Molecular Biology 11 42-48.
30. Lane SJ, Atkinson BA, Swaminathan R & Lee TH 1996 Hypothalamic-pituitary-adrenal axis in corticosteroid-resistant bronchial asthma. American Journal of Respiratory and Critical Care Medicine 153 557-560.
31. Lane SJ, Adcock IM, Richards D, Hawrylowicz C, Barnes PJ & Lee TH 1998 Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes. Journal of Clinical Investigation 102 2156-2164.
32. Lasa M, Brook M, Saklatvala J & Clark AR 2001 Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen- activated protein kinase p38. Molecular and Cellular Biology 21 771-780.
33. Lasa M, Abraham SM, Boucheron C, Saklatvala J & Clark AR 2002 Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Molecular and Cellular Biology 22 7802-7811.
34. Leung DY & Bloom JW 2003 Update on glucocorticoid action and resistance. Journal of Allergy and Clinical Immunology 111 3-22.
35. Leung DY, Martin RJ, Szefler SJ, Sher ER, Ying S, Kay AB & Hamid Q 1995 Dysregulation of interleukin 4, interleukin 5 and interferon gamma gene expression in steroid-resistant asthma. Journal of Experimental Medicine 181 33-40.
36. Malchoff DM, Brufsky A, Reardon G, McDermott P, Javier EC, Bergh CH, Rowe D & Malchoff CD 1993 A mutation of the glucocorticoid receptor in primary cortisol resistance. Journal of Clinical Investigation 91 1918-1925.
37. Matthews JG, Ito K, Barnes PJ & Adcock IM 2000 Corticosteroid- resistant and corticosteroid-dependent asthma: two clinical phenotypes can be associated with the same in vitro defects in GR nuclear translocation and acetylation of histone H4. American Journal of Respiratory and Critical Care Medicine 161 A189.
38. Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, Bock R, Gass P, Schmid W, Herrlich P, Angel P & Schutz G 1998 DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93 531-541.
39. Rider LG, Hirasawa N, Santini F & Beaven MA 1996 Activation of the mitogen-activated protein kinase cascade is suppressed by low concentrations of dexamethasone in mast cells. Journal of Immunology 157 2374-2380.
40. Rogatsky I, Logan SK & Garabedian MJ 1998 Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase. PNAS 95 2050-2055.
41. Savory JA, Hsu B, Laquian IR, Giffin W, Reich T, Hache RG & Lefebvre YA 1999 Discrimination between NL1- and NL2- mediated nuclear localization of the glucocorticoid receptor. Molecular and Cellular Biology 19 1025-1037.
42. Schacke H, Docke WD & Asadullah K 2002a Mechanisms involved in the side effects of glucocorticoids. Pharmacology and Therapeutics 96 23-43.
43. Schacke H, Hennekes H, Schottelius A, Jaroch S, Lehmann M, Schmees N, Rehwinkel H & Asadullah K 2002b SEGRAs: a novel class of anti-inflammatory compounds. Ernst Schering Research Foundation Workshop 40 357-371.
44. Shaulian E & Karini M 2002 AP-1 as a regulator of cell life and death. Nature Cell Biology 4 E131-E136.
45. Sher ER, Leung DY, Surs W, Kam JC, Zieg G, Kamada AK & Szefler SJ 1994 Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. Journal of Clinical Investigation 93 33-39.
46. Sousa AR, Lane SJ, Soh C & Lee TH 1999 In vivo resistance to corticosteroids in bronchial asthma is associated with enhanced phosyphorylation of JUN N-terminal kinase and failure of prednisolone to inhibit JUN N-terminal kinase phosphorylation. Journal of Allergy and Clinical Immunology 104 565-574.
47. Sousa AR, Lane SJ, Cidlowski JA, Staynov DZ & Lee TH 2000 Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor beta-isoform. Journal of Allergy and Clinical Immunology 105 943-950.
48. Swantek JL, Cobb MH & Geppert TD 1997 Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK. Molecular and Cellular Biology 17 6274-6282.
49. Urnov FD & Wolffe AP 2001 Chromatin remodeling and transcriptional activation: the cast (in order of appearance). Oncogene 20 2991-3006.
50. Vayssiere BM, Dupont S, Choquart A, Petit F, Garcia T, Marchandeau C, Gronemeyer H & Resche RM 1997 Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo. Molecular Endocrinology 11 1245-1255.
51. Wang CY, Bassuk AG, Boise LH, Thompson CB, Bravo R & Leiden JM 1994 Activation of the granulocyte-macrophage colony-stimulating factor promoter in T cells requires cooperative binding of Elf-1 and AP-1 transcription factors. Molecular and Cellular Biology 14 1153-1159.